These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1279849)

  • 1. Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome.
    Mor E; Gonwa TA; Husberg BS; Goldstein RM; Klintmalm GB
    Transplantation; 1992 Nov; 54(5):821-4. PubMed ID: 1279849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies in prophylactic immunosuppression after liver transplantation. A randomized controlled trial comparing OKT3 and anti-IL-2 receptor monoclonal antibody LO-Tact-1.
    Reding R; Vraux H; de Ville de Goyet J; Sokal E; de Hemptinne B; Latinne D; Rahier J; Jamart J; Vincenzotto C; Cormont F
    Transplantation; 1993 Mar; 55(3):534-41. PubMed ID: 8456474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction therapy with OKT3 in pediatric liver-transplant recipients.
    Ryckman FC; Schroeder TJ; Pedersen SH; Dittrich VS; Balistreri WF
    Transplant Sci; 1994 Dec; 4 Suppl 1():S20-5. PubMed ID: 7627451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 conversion therapy in pediatric liver transplantation.
    Egawa H; Esquivel CO; So SK; Cox K; Concepcion W; Lawrence L
    Transplantation; 1994 Apr; 57(8):1169-73. PubMed ID: 7513911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
    Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
    Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OKT3 rescue for steroid-resistant rejection in adult liver transplantation.
    Solomon H; Gonwa TA; Mor E; Holman MJ; Gibbs J; Watemberg I; Netto G; Goldstein RM; Husberg BS; Klintmalm GB
    Transplantation; 1993 Jan; 55(1):87-91. PubMed ID: 8420070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.
    Eckhoff DE; McGuire BM; Frenette LR; Contreras JL; Hudson SL; Bynon JS
    Transplantation; 1998 Jan; 65(2):180-7. PubMed ID: 9458011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases].
    Cherqui D; Duvoux C; Charlotte F; Humeres R; Lauzet JY; Métreau JM; Salvat A; Rotman N; Julien M; Fagniez PL
    Gastroenterol Clin Biol; 1994; 18(2):115-22. PubMed ID: 8013792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoral compared to Sandimmune is associated with a decrease in histologic severity of rejection in patients undergoing primary liver transplantation.
    Graziadei IW; Wiesner RH; Marotta PJ; Porayko MK; Dahlke LJ; Wilson SM; Steers JL; Krom RA
    Transplantation; 1997 Sep; 64(5):726-31. PubMed ID: 9311710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
    Millis JM; Woodle ES; Piper JB; Bruce DS; Newell KA; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR
    Transplantation; 1996 May; 61(9):1365-9. PubMed ID: 8629298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus for steroid-resistant liver rejection in children.
    Jara P; Robledo MJ; Frauca E; Gonzalez-Filgueira MD; Hierro L; de la Vega A; Camarena C; Martín-Ibáñez M; Murcia J; López-Santamaría M; Larrauri J; Díaz MC; Gámez M
    Transpl Int; 1998; 11 Suppl 1():S275-7. PubMed ID: 9664996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of immunosuppressive regimen on acute rejection and liver graft function.
    Ziolkowski J; Paczek L; Niewczas M; Senatorski G; Oldakowska-Jedynak U; Wyzgal J; Foroncewicz B; Mucha K; Zegarska J; Nyckowski P; Zieniewicz K; Patkowski W; Krawczyk M; Ziarkiewicz-Wroblewska B; Gornicka B
    Transplant Proc; 2003 Sep; 35(6):2281-3. PubMed ID: 14529915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
    Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
    Transplantation; 2000 Jun; 69(12):2573-80. PubMed ID: 10910279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.
    Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL
    Transplantation; 1987 Jan; 43(1):91-5. PubMed ID: 3099442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CsA levels in the early posttransplant period--predictive of chronic rejection in liver transplantation?
    Soin AS; Rasmussen A; Jamieson NV; Watson CJ; Friend PJ; Wight DG; Calne RY
    Transplantation; 1995 Apr; 59(8):1119-23. PubMed ID: 7732557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients.
    McKee M; Segev D; Wise B; Case B; Neu A; Fivush B; Colombani P
    J Pediatr Surg; 1997 May; 32(5):688-90. PubMed ID: 9165452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing, significance, and prognosis of late acute liver allograft rejection.
    Anand AC; Hubscher SG; Gunson BK; McMaster P; Neuberger JM
    Transplantation; 1995 Nov; 60(10):1098-103. PubMed ID: 7482715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
    Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
    Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
    Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
    Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.